Literature DB >> 312753

Immune status in Crohn's disease. 3. Peripheral blood B lymphocytes, enumerated by means of F(ab)2-antibody fragments, Null and T lymphocytes.

I O Auer, S Götz, E Ziemer, H Malchow, H Ehms.   

Abstract

In the peripheral blood of patients with Crohn's disease (CD) the numerical distribution of the three major B lymphocyte subsets was determined by the identification of surface immunoglobulins using F(ab)(2)-antibody fragments. T cell counts were also obtained and the number of null cells was calculated. Twenty-eight patients with Crohn's disease including 14 patients with previously untreated and very short-standing disease (group CD 1) and 14 patients with long-standing and/or previous drug treated disease (group CD 2) were compared with 28 sex and age-matched normals as well as with 13 patients with acute inflammatory bowel disease (group D). Patients in group D and inactive patients of group CD 1 showed a significant absolute lymphocytosis due to an increase in both the three B cell subsets and the T cells, without changes in the null cells. While the proportion of T cells was normal, there was a significant relative B lymphocytosis and a relative null cytopenia in these patients. Active CD 1 patients, however, showed significantly lower absolute lymphocyte and T cell numbers. In group CD 2, there was a significant absolute lymphopenia caused by an equal decrease in B and T cells. Highly active CD 2 patients showed higher absolute null cell counts than inactive patients. With increasing disease duration there was a significant decrease of the relative and absolute B cell concentrations. The data obtained suggest that T and B cell populations in the peripheral blood are reduced in certain patients with Crohn's disease and that this occurs secondarily to activity of disease, chronicity of disease, and the effects of therapy.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312753      PMCID: PMC1412387          DOI: 10.1136/gut.20.4.261

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  Immune status in Crohn's disease. 2. Originally unimpaired primary cell mediated immunity in vitro.

Authors:  I O Auer; C Buschmann; E Ziemer
Journal:  Gut       Date:  1978-07       Impact factor: 23.059

2.  Immune complexes in ulcerative colitis and Crohn's disease.

Authors:  H J Hodgson; B J Potter; D P Jewell
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

3.  F(ab')2 reagents are not required if goat, rather than rabbit, antibodies are used to detect human surface immunoglobulin.

Authors:  E L Alexander; S K Sanders
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

4.  Peripheral blood T and B cells in chronic inflammatory bowel disease.

Authors:  R G Strickland; S Korsmeyer; R D Soltis; I D Wilson; R C Williams
Journal:  Gastroenterology       Date:  1974-10       Impact factor: 22.682

5.  Inflammatory bowel disease. Cytophilic antibody and the cytotoxicity of lymphocytes for colonic cells in vitro.

Authors:  T G Shorter; K A Huizenga; R J Spencer; J Aas; S K Guy
Journal:  Am J Dig Dis       Date:  1971-08

6.  Escherichia Coli O:14 and colon hemagglutinating antibodies in inflammatory bowel disease.

Authors:  W R Thayer; M Brown; M H Sangree; J Katz; T Hersh
Journal:  Gastroenterology       Date:  1969-09       Impact factor: 22.682

7.  Immune status in Crohn's disease. I. Leukocyte and lymphocyte subpopulations in peripheral blood.

Authors:  I O Auer; W Wechsler; E Ziemer; H Malchow; H Sommer
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

8.  The effect of acute and prolonged administration of prednisolone and ACTH on lymphocyte subpopulations.

Authors:  D A Cooper; V Petts; E Luckhurst; R Penny
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

9.  Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.

Authors:  R J Winchester; J B Winfield; F Siegal; P Wernet; Z Bentwich; H G Kunkel
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

10.  [Lipid A antibody titers in Crohn's disease (author's transl)].

Authors:  P Schüssler; W Kruis; W Marget
Journal:  Klin Wochenschr       Date:  1976-11-01
View more
  11 in total

1.  CD5+ B cells are decreased in peripheral blood of patients with Crohn's disease.

Authors:  G A Neil; R W Summers; B A Cheyne; C Capenter; W L Huang; G S Kansas; T J Waldschmidt
Journal:  Dig Dis Sci       Date:  1992-09       Impact factor: 3.199

2.  Mononuclear cells in peripheral venous blood of patients with Crohn's disease: preoperative status and postoperative course, influence of duration, activity and extent of disease.

Authors:  G Schürmann; M Betzler; B von Ditfurth; U Abel; C Herfarth
Journal:  Langenbecks Arch Chir       Date:  1991

Review 3.  The immunologic basis of inflammatory bowel disease.

Authors:  W Strober; S P James
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

4.  Immune status in Crohn's disease. V. Decreased in vitro natural killer cell activity in peripheral blood.

Authors:  I O Auer; E Ziemer; H Sommer
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

5.  Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease.

Authors:  G Sieber; F Herrmann; M Zeitz; H Teichmann; H Rühl
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

6.  Alteration in T lymphocyte subpopulations in inflammatory bowel disease.

Authors:  R M Victorino; H J Hodgson
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

7.  Influence of nutritional status on immune functions in patients with Crohn's disease.

Authors:  A D Harries; V A Danis; R V Heatley
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

8.  Immune status in Crohn's disease. 4. In vitro antibody dependent cell mediated cytotoxicity in peripheral blood.

Authors:  I O Auer; E Ziemer
Journal:  Klin Wochenschr       Date:  1980-08-01

9.  Enumeration of lymphocyte populations defined by surface markers in the whole blood of patients with Crohn's disease.

Authors:  E O Pepys; E A Fagan; G A Tennent; V S Chadwick; M B Pepys
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

10.  E rosetting lymphocytes in inflammatory bowel disease. An analysis using monoclonal antibodies.

Authors:  K Makiyama; W S Selby; D P Jewell
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.